I'Rom Group

Tokyo, Japan Founded: 1997 • Age: 29 yrs
Japanese clinical research enabler and providing site management office services
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About I'Rom Group

I'Rom Group is a company based in Tokyo (Japan) founded in 1997. I'Rom Group has completed 1 acquisition, including CMAX. I'Rom Group operates in a competitive market with competitors including Elligo, Acurian, Inclinix, CenExel and ePatientFinder, among others.

  • Headquarter Tokyo, Japan
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of I'Rom Group

Premium access

Detailed funding history for IRom Group

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by I'Rom Group

I'Rom Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CMAX.

Investments
Premium access

Investment portfolio details for IRom Group

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Early-phase clinical trials are conducted by CMAX laboratory in Adelaide.
Locked Locked 1993 Locked
Premium access

Complete acquisition details for IRom Group

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - IRom Group

Premium access

Detailed financials for IRom Group

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

I'rom Group Comparisons

I'Rom Group Primary company
Description
Japanese clinical research enabler and providing site manage...
Location
Tokyo, Japan
Founded Year
1997
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for IRom Group

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of I'Rom Group

I'Rom Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elligo, Acurian, Inclinix, CenExel and ePatientFinder, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Patient recruitment and site activation services are provided by Elligo.
Locked Locked Locked
Patient enrollment and retention solutions for clinical trials are offered.
Locked Locked Locked
Customized solutions for clinical trial enrollment are provided.
Locked Locked Locked
Research site management and patient recruitment services are provided.
Locked Locked Locked
Clinical trial recruitment service company
Locked Locked Locked
Provider of site management and patient recruitment services
Premium access

Detailed competitors of IRom Group

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on I'rom Group

Premium access

Complete news archive for IRom Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about I'Rom Group

I'Rom Group was founded in 1997.

I'Rom Group is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.

IRom Group was founded in 1997 in Tokyo, Japan, within the clinical research sector. Site management office services are offered, including the establishment of medical malls across Japan for access to clinical trial sites. In 2007, Icros was created to deliver clinical research organization services. Capabilities in genetic drug development, cell treatment, and regenerative medicine were added through the 2014 acquisition of DNAVEC.

I'Rom Group's top competitors include Velocity Clinical Research, Elligo and Acurian.

I'Rom Group has made 1 acquisition, including CMAX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available